Close

Samalizumab (TAB-210)

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human CD200 Therapeutic Antibody TAB-210 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant monoclonal antibody to CD200. Samalizumab is a humanized monoclonal antibody designed for oncology indications.
  • Target
  • CD200
  • Type
  • IgG2 / G4 - kappa
  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, WB and most other immunological methods.
  • CAS
  • 1073059-33-2
  • Specificity
  • Tested positive against native human antigen.
  • Protein Construction
  • Immunoglobulin, anti-(CD200 (antigen)) (human-mouse monoclonal ALXN6000 heavy chain), disulfide with human-mouse monoclonal ALXN6000 kappa-chain, dimer
  • Molecular Weight
  • 147700
  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.
  • Size
  • 1mg
  • Storage
  • At -20°C for one year.

BACKGROUND

  • Antigen Description
  • Costimulates T-cell proliferation. May regulate myeloid cell activity in a variety of tissues.
  • Function
  • identical protein binding; protein binding;
  • Synonyms
  • CD200; CD200 molecule; antigen identified by monoclonal MRC OX 2 , CD200 antigen , MOX1, MOX2; OX-2 membrane glycoprotein; MRC; OX 2; CD200 antigen; MRC OX-2 antigen; antigen identified by monoclonal MRC OX-2; MOX1; MOX2; OX-2;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us